Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy

Citation
B. Canaud et al., Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy, NEPH DIAL T, 16(11), 2001, pp. 2181-2187
Citations number
34
Categorie Soggetti
Urology & Nephrology
Journal title
NEPHROLOGY DIALYSIS TRANSPLANTATION
ISSN journal
09310509 → ACNP
Volume
16
Issue
11
Year of publication
2001
Pages
2181 - 2187
Database
ISI
SICI code
0931-0509(200111)16:11<2181:CIRAPI>2.0.ZU;2-J
Abstract
Background. Repetitive exposure to cytokine-inducing substances (pyrogens) results in chronic inflammation, which may significantly contribute to some of the long-term complications in dialysis patients. On-line dialysis moda lities, such as on-line haemodiafiltration (HDF), raise particular concerns because of the administration of infusate prepared from potentially contam inated dialysis fluid. Hence, great retention capability for pyrogens is of critical importance for the safe performance of on-line systems. Methods. The microbiological safety of a novel on-line system, ONLINEplus(R ), was assessed in clinical practice in five centres for 3 months. Infusate and dialysis fluid were regularly monitored for microbial counts, endotoxi ns, and cytokine-inducing activity. Levels of interleukin-1 receptor antago nist (IL-1Ra) were determined in supernatants of whole blood incubated eith er under pyrogen-free conditions (spontaneous cytokine production) or follo wing low-dose endotoxin exposure (LPS-stimulated cytokine production). Results. We railed to detect microorganisms or endotoxin contamination of i nfusate during the entire study period. Moreover, neither infusate nor dial ysis fluid demonstrated cytokine-inducing activity. Intradialytic IL-1Ra in duction was not detected, as there was no difference between pre- and post- session values for both spontaneous and LPS-stimulated IL-1Ra production (1 15 +/- 26 vs 119 +/- 27 and 2445 +/- 353 vs 2724 +/- 362 pg/10(6) white blo od cells (WBC), respectively). Neither the number of immunocompetent cells nor their capacity to produce IL-1Ra declined during this period, indicatin g that cells were not significantly stimulated during treatment. Spontaneou s and LPS-induced ex vivo IL-1Ra generation remained unchanged after 3 mont hs of on-line HDF therapy as compared with the start of the study (71 +/- 3 0 pre- vs 48 +/- 14 post-study, and 2559 +/- 811 vs 2384 +/- 744 pg/10(6) W BC, respectively). Conclusions. The present on-line system performed safely from a microbiolog ical view-point as both the dialysis fluid and infusate were consistently f ree of microorganisms. endotoxins, and cytokine-inducing substances. As a r esult, on-line HDF therapy had no effect upon the chronic inflammatory resp onses in end-stage renal disease patients.